Bertero Alessandro, Yiangou Loukia, Brown Stephanie, Ortmann Daniel, Pawlowski Matthias, Vallier Ludovic
Wellcome Trust-MRC Stem Cell Institute, Anne McLaren Laboratory, University of Cambridge, Cambridge, United Kingdom.
Department of Surgery, University of Cambridge, Cambridge, United Kingdom.
Curr Protoc Stem Cell Biol. 2018 Feb 28;44:5C.4.1-5C.4.48. doi: 10.1002/cpsc.45.
The difficulties involved in conditionally perturbing complex gene expression networks represent major challenges toward defining the mechanisms controlling human development, physiology, and disease. We developed an OPTimized inducible KnockDown (OPTiKD) platform that addresses the limitations of previous approaches by allowing streamlined, tightly-controlled, and potent loss-of-function experiments for both single and multiple genes. The method relies on single-step genetic engineering of the AAVS1 genomic safe harbor with an optimized tetracycline-responsive cassette driving one or more inducible short hairpin RNAs (shRNAs). OPTiKD provides homogeneous, dose-responsive, and reversible gene knockdown. When implemented in human pluripotent stem cells (hPSCs), the approach can be then applied to a broad range of hPSC-derived mature cell lineages that include neurons, cardiomyocytes, and hepatocytes. Generation of OPTiKD hPSCs in commonly used culture conditions is simple (plasmid based), rapid (two weeks), and highly efficient (>95%). Overall, this method facilitates the functional annotation of the human genome in health and disease. © 2018 by John Wiley & Sons, Inc.
有条件地干扰复杂基因表达网络所涉及的困难,是定义控制人类发育、生理学和疾病机制的主要挑战。我们开发了一种优化的诱导性敲低(OPTiKD)平台,该平台通过允许对单个和多个基因进行简化、严格控制且有效的功能丧失实验,解决了以往方法的局限性。该方法依赖于对AAVS1基因组安全港进行单步基因工程改造,使用优化的四环素响应盒驱动一个或多个诱导性短发夹RNA(shRNA)。OPTiKD可实现均匀、剂量响应性和可逆的基因敲低。当应用于人类多能干细胞(hPSC)时,该方法随后可应用于广泛的hPSC衍生的成熟细胞谱系,包括神经元、心肌细胞和肝细胞。在常用培养条件下生成OPTiKD hPSC很简单(基于质粒)、快速(两周)且高效(>95%)。总体而言,该方法有助于在健康和疾病状态下对人类基因组进行功能注释。© 2018约翰威立国际出版公司。